Novartis Services Inc.
H-1B Sponsorship & Salary Data — Government-Verified
$174,439Avg. Salary
18Filings
16+Job Titles
November 2025Last Filing
According to TheRealSalaries.com analysis of official US Department of Labor filings (October 2024 - December 2025), Novartis Services Inc. pays a median H-1B salary of $151,819 — 25% above the national median of $121,514, ranking in the top 16% of 13,957 ranked H-1B sponsors. Based on 18 certified Labor Condition Applications.
Section 1
What does Novartis Services Inc. pay?
Novartis Services Inc. 's H-1B filings show an average salary of $174,439 based on 18 certified LCA applications. Salaries range from $100,048 to $272,418.
$174,439
Average
$151,819
Median
$100,048
Minimum
$272,418
Maximum
Recent H-1B Filings
| Job Title | Salary |
|---|---|
| Senior Specialist, DDIT Operations | $136,989 |
| Specialist, Quality Control | $100,048 |
| Executive Director, TAS Oncology Precision Medicine | $223,142 |
| Executive Director, TAS Oncology Precision Medicine | $223,142 |
| Associate Director, Policy Analytics | $183,186 |
| Manager, Financial Controls and Compliance | $118,810 |
| Associate Director, Site Lead (ITOT) | $140,899 |
| Associate Director, Int. New Customer Platforms | $151,819 |
| TA Strategy Executive Director, CV | $236,038 |
| VP, Head Global IP Strategy, US Tax & Insurance | $272,418 |
| Director, Precision Diagnostics | $178,922 |
| Director, Therapeutic Area Strategy (Immunology) | $147,576 |
| TA Strategy Executive Director, CV | $236,038 |
| Director, Access International | $218,650 |
| Associate Director “ US P2P Data & Digital | $132,371 |
| Manager, FRA | $115,731 |
| Associate Director, Implementation Lead | $182,957 |
| HCM People Analytics Lead | $141,170 |
Section 2
States with Novartis Services Inc. H-1B Filings
Similar Companies
Section 3
All salaries above must meet the Department of Labor's wage floor — see how the H-1B prevailing wage levels work, or browse all sponsor companies.
Source: US Department of Labor LCA Disclosure Data. Last updated: Q1 FY2025.